ZA201200755B - Combination of proanthocyanidns such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders as atherosclerosis - Google Patents

Combination of proanthocyanidns such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders as atherosclerosis

Info

Publication number
ZA201200755B
ZA201200755B ZA2012/00755A ZA201200755A ZA201200755B ZA 201200755 B ZA201200755 B ZA 201200755B ZA 2012/00755 A ZA2012/00755 A ZA 2012/00755A ZA 201200755 A ZA201200755 A ZA 201200755A ZA 201200755 B ZA201200755 B ZA 201200755B
Authority
ZA
South Africa
Prior art keywords
proanthocyanidns
pycnogenol
atherosclerosis
treatment
combination
Prior art date
Application number
ZA2012/00755A
Other languages
English (en)
Inventor
Gianni Belcaro
Carolina Bukki
Victor Ferrari
Original Assignee
Horphag Res Ip (Pyc) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42083898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201200755(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Horphag Res Ip (Pyc) Ltd filed Critical Horphag Res Ip (Pyc) Ltd
Publication of ZA201200755B publication Critical patent/ZA201200755B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA2012/00755A 2009-08-12 2012-01-31 Combination of proanthocyanidns such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders as atherosclerosis ZA201200755B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2009006525 2009-08-12
PCT/IB2010/053637 WO2011018763A1 (en) 2009-08-12 2010-08-11 Combination of proantocycidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis

Publications (1)

Publication Number Publication Date
ZA201200755B true ZA201200755B (en) 2012-09-26

Family

ID=42083898

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/00755A ZA201200755B (en) 2009-08-12 2012-01-31 Combination of proanthocyanidns such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders as atherosclerosis

Country Status (18)

Country Link
US (1) US9308230B2 (cg-RX-API-DMAC7.html)
EP (1) EP2464348B1 (cg-RX-API-DMAC7.html)
JP (1) JP5711231B2 (cg-RX-API-DMAC7.html)
KR (1) KR101678254B1 (cg-RX-API-DMAC7.html)
CN (1) CN102573834B (cg-RX-API-DMAC7.html)
AU (1) AU2010283453B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012002935A2 (cg-RX-API-DMAC7.html)
CA (1) CA2769764C (cg-RX-API-DMAC7.html)
CL (1) CL2012000347A1 (cg-RX-API-DMAC7.html)
DK (1) DK2464348T3 (cg-RX-API-DMAC7.html)
ES (1) ES2426314T3 (cg-RX-API-DMAC7.html)
MX (1) MX2012001111A (cg-RX-API-DMAC7.html)
MY (1) MY162572A (cg-RX-API-DMAC7.html)
PH (1) PH12012500291A1 (cg-RX-API-DMAC7.html)
RU (1) RU2570733C2 (cg-RX-API-DMAC7.html)
SG (1) SG178203A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011018763A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201200755B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103027908A (zh) * 2012-11-19 2013-04-10 何晓涛 Aphanamixoid A在制备治疗动脉粥样硬化药物中的应用
EP2829277A1 (en) 2013-07-26 2015-01-28 Natac Biotech, S.L. Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease
WO2015184101A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in neonatal and young non-human animals
WO2015184109A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in adult non-human animals
WO2016046375A1 (en) * 2014-09-25 2016-03-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Theobroma cacao extract for use in the treatment or prevention of receptor tyrosine kinases related disorders
US20180021297A1 (en) * 2015-02-26 2018-01-25 Jaguar Health, Inc. Use Of Croton- Or Calophyllum-Derived Proanthocyanidin Polymers Or Botanical Extracts In Combination With Rifaximin For The Treatment Of Diarrhea In Non-Human Animals
GB201801986D0 (en) * 2018-02-07 2018-03-28 Ip Science Ltd Anthocyanins and used thereof
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1427100A (fr) 1964-12-14 1966-02-04 Ile De Rech Pharma Et Therapeu Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
BE897965A (fr) * 1983-10-11 1984-01-30 Bago Sa Labor Composition therapeutique exercant une activite anti-agglomeration des plaquettes
US5720956A (en) 1996-04-10 1998-02-24 Rohdewald; Peter Method of controlling the reactivity of human blood platelets by oral administration of the extract of the maritime pine (pycnogenol)
JP3510526B2 (ja) * 1999-05-24 2004-03-29 キッコーマン株式会社 抗動脈硬化症食品
DE60019314T2 (de) * 1999-09-10 2006-04-27 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen
JP3260134B2 (ja) 1999-10-08 2002-02-25 信孝 鈴木 月経困難症、子宮内膜症の治療薬
JP3495712B2 (ja) 2001-02-19 2004-02-09 株式会社ファンケル 食品組成物
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
ITGE20020026A1 (it) * 2002-03-25 2003-09-25 Segre Silvia Perella Composto da impiegare nel trattamento scleroterapico,nell'insufficienza venosa e nelle alterazioni del microcircolo.
JP2005023032A (ja) * 2003-07-03 2005-01-27 Toyo Shinyaku:Kk 動脈硬化予防剤
EP1523894B1 (de) * 2003-10-18 2007-02-21 Cognis IP Management GmbH Zubereitung zur oralen Aufnahme
JP2005237203A (ja) * 2004-02-24 2005-09-08 Haba Laboratories Inc ：喫煙によって生ずるｄｎａ酸化損傷を抑制するに有効な食品組成物
JP2007530574A (ja) * 2004-03-23 2007-11-01 ライフライン・ニュートラシューティカルズ・コーポレーション 哺乳動物において炎症及び酸化ストレスを軽減させるための組成物及び方法
JP4708744B2 (ja) * 2004-07-15 2011-06-22 株式会社シールド・ラボ 血小板凝集抑制組成物
JP5139629B2 (ja) * 2005-06-28 2013-02-06 江崎グリコ株式会社 ＴＮＦ−αおよび一酸化窒素産生抑制剤
WO2007084648A2 (en) 2006-01-20 2007-07-26 Mars, Incorporated Mixed 4→6 procyanidin dimers and their use
US20070265211A1 (en) * 2006-05-12 2007-11-15 Matthias Rath Novel composition and method effective in inhibiting the atherogenic process
KR100846292B1 (ko) 2007-07-20 2008-07-16 인타글리오주식회사 비수계 분산형 클렌징밤 조성물

Also Published As

Publication number Publication date
CL2012000347A1 (es) 2013-09-23
CA2769764A1 (en) 2011-02-17
JP5711231B2 (ja) 2015-04-30
CN102573834A (zh) 2012-07-11
KR101678254B1 (ko) 2016-11-21
CN102573834B (zh) 2015-04-29
CA2769764C (en) 2017-04-18
BR112012002935A2 (pt) 2016-04-05
DK2464348T3 (da) 2013-07-29
MX2012001111A (es) 2012-06-01
KR20120103758A (ko) 2012-09-19
US9308230B2 (en) 2016-04-12
US20120164244A1 (en) 2012-06-28
RU2012104215A (ru) 2013-09-20
AU2010283453A8 (en) 2012-06-07
ES2426314T3 (es) 2013-10-22
RU2570733C2 (ru) 2015-12-10
AU2010283453B2 (en) 2014-10-09
MY162572A (en) 2017-06-30
WO2011018763A1 (en) 2011-02-17
SG178203A1 (en) 2012-03-29
AU2010283453A1 (en) 2012-02-23
PH12012500291A1 (en) 2016-10-12
WO2011018763A8 (en) 2012-03-15
JP2013501774A (ja) 2013-01-17
EP2464348A1 (en) 2012-06-20
EP2464348B1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
ZA201200755B (en) Combination of proanthocyanidns such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders as atherosclerosis
HRP20190521T1 (hr) Novi pripravci za prevenciju i/ili liječenje poremećaja lizosomskog nakupljanja
EP2405755A4 (en) METHOD AND COMPOSITIONS FOR TREATING METABOLISM AND CARDIOVASCULAR DISEASES
EP2334217A4 (en) CENTRIFUGE MODULE AND VERTICAL PROPELLER CENTRIFUGE
IL212579A0 (en) Fruit extracts and methods of producing the same
IL184312A0 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
PT2318033T (pt) Composições para o tratamento de dor e/ou inflamação
EP2434888A4 (en) ANHYDROPENTITOLS KETTO ESTERS AND USES THEREOF
EP2373610A4 (en) PLANT EXTRACTS FROM ACRONYCHIA SPECIES AND THEIR USE
IL207377A0 (en) Plant capable of bearing seedless fruits and methods of producting variety bearing seedless fruits
PT2425723T (pt) Processo e instalação para produzir produtos de açúcar a partir de uvas
GB2455585B (en) Capsicum seeds for the treatment of eczema and dermatitis
IL216853A (en) Agricultural preparations containing alkoxylation products and methods for the treatment of plants and seeds with these preparations
IL192428A0 (en) Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing
HUE052007T2 (hu) Növényi olajak átészterezése
PL2328402T3 (pl) Sposoby i kompozycje do wydłużenia okresu przechowywania owoców
ZA201204099B (en) Evaporation element and process using same
PL388575A1 (pl) Nowy 7-O-β -D-4'''metoksyglukopiranozyd 8-prenylonaringeniny i sposób jego wytwarzania
GB201010110D0 (en) Fruit and vegetable system
EP2257173A4 (en) METHODS OF TREATING CARDIOVASCULAR DISORDERS ASSOCIATED WITH ATHEROSCLEROSIS
PL388612A1 (pl) Nowa 7-O-n-pentylo-8-prenylonaringenina oraz sposób jej otrzymywania
GB0909198D0 (en) Methods and composition for treating NF-kappa B mediated disorders
GB0817434D0 (en) Methods of obtaining novel plants and plants obtainable thereby
HU0800092D0 (en) Process and product symptomatic treatment psoriasis
GB0808730D0 (en) Compositions and methods for the prevention and treatment of schistosomiasis